The FDA just made a move that changes everything for my patients. For nearly two years, some of the most clinically promising peptides in longevity and autoimmune medicine were locked away alphabiomedlabs #dihexa #neuroplasticityresearch #hgfcmet #neurosciencescience Alpha BioMed Important Update on FDA Changes Concerning Peptides The FDA's Category 2 list restricted 19 peptides from compounding. Now, approximately 14 of them may be coming back. HHS has signaled that peptides previously barred from compounding spanning categories like